Search Press releases Keywords From To 25 Apr 2018 UCB First Three Months Interim Report 2018: UCB tracking well towards full year financial outlook Read More 19 Apr 2018 UCB to expand epilepsy portfolio with strategic acquisition of Midazolam Nasal Spray from Proximagen Read More 4 Apr 2018 UCB strengthens research capabilities with acquisition of Element Genomics, a Duke University biotech spin-off Read More 2 Apr 2018 New publication on Cimzia® (certolizumab pegol) shows psoriatic arthritis patients achieved robust treatment targets and sustained improvements across multiple disease domains Read More 30 Mar 2018 Acquisition of own shares Read More 30 Mar 2018 Transparency notification The Capital Group Companies Inc. Read More Pagination First page Previous page Previous … Page 71 Page 72 Page 73 Page 74 Current page 75 Page 76 Page 77 Page 78 Page 79 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
